Jubilant Pharmova Limited (BOM:530019)
985.25
-21.85 (-2.17%)
At close: May 26, 2026
Jubilant Pharmova Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 3,985 | 8,394 | 771 | -610 | 4,139 |
Depreciation & Amortization | 4,404 | 3,066 | 3,279 | 3,348 | 2,928 |
Other Amortization | - | 620 | 540 | 742 | 735.2 |
Loss (Gain) From Sale of Assets | 55 | -13 | -2 | 27 | 33.7 |
Asset Writedown & Restructuring Costs | - | - | - | 1,450 | 153.83 |
Loss (Gain) From Sale of Investments | -31 | 17 | -2 | 50 | -1.47 |
Loss (Gain) on Equity Investments | 3 | 5 | -511 | -123 | 99.83 |
Stock-Based Compensation | 118 | 43 | 85 | 37 | 11.24 |
Other Operating Activities | 2,340 | -2,529 | 3,022 | 1,143 | 2,059 |
Change in Accounts Receivable | -995 | 242 | 494 | 386 | -721.37 |
Change in Inventory | -449 | 785 | 908 | -647 | -956.47 |
Change in Accounts Payable | 1,099 | 553 | 232 | 2,105 | 1.58 |
Change in Other Net Operating Assets | 1,739 | -462 | 897 | -1,301 | -106.61 |
Operating Cash Flow | 12,268 | 10,721 | 9,713 | 6,607 | 8,375 |
Operating Cash Flow Growth | 14.43% | 10.38% | 47.01% | -21.11% | -53.06% |
Capital Expenditures | -14,491 | -11,156 | -8,977 | -8,145 | -6,000 |
Sale of Property, Plant & Equipment | 1,021 | 50 | 97 | 186 | 35.18 |
Investment in Securities | -165 | 9,507 | -21 | -117 | 2,121 |
Other Investing Activities | 1,035 | 6,476 | 2,822 | 2,632 | 40.21 |
Investing Cash Flow | -12,600 | 4,877 | -6,079 | -5,444 | -3,804 |
Short-Term Debt Issued | - | 225 | - | 1,943 | 439.99 |
Long-Term Debt Issued | 25,713 | 49 | 1,172 | 28,104 | 2,032 |
Total Debt Issued | 25,713 | 274 | 1,172 | 30,047 | 2,472 |
Short-Term Debt Repaid | -565 | - | -617 | - | - |
Long-Term Debt Repaid | -20,841 | -11,602 | -1,371 | -28,431 | -647.85 |
Total Debt Repaid | -21,406 | -11,602 | -1,988 | -28,431 | -647.85 |
Net Debt Issued (Repaid) | 4,307 | -11,328 | -816 | 1,616 | 1,824 |
Issuance of Common Stock | 10 | 9 | - | - | - |
Repurchase of Common Stock | -187 | -56 | -274 | -40 | - |
Common Dividends Paid | -795 | -796 | -798 | -801 | -800.53 |
Other Financing Activities | -2,386 | -2,356 | -2,437 | -2,342 | -1,349 |
Financing Cash Flow | 949 | -14,527 | -4,325 | -1,567 | -325.99 |
Foreign Exchange Rate Adjustments | 1,171 | 248 | 116 | 705 | 572.88 |
Net Cash Flow | 1,788 | 1,319 | -575 | 301 | 4,819 |
Free Cash Flow | -2,223 | -435 | 736 | -1,538 | 2,376 |
Free Cash Flow Growth | - | - | - | - | -81.10% |
Free Cash Flow Margin | -2.69% | -0.60% | 1.10% | -2.45% | 3.88% |
Free Cash Flow Per Share | -13.99 | -2.74 | 4.63 | -9.66 | 14.92 |
Cash Interest Paid | 2,383 | 2,356 | 2,437 | 2,342 | 1,349 |
Cash Income Tax Paid | 2,094 | 2,384 | 2,077 | 2,043 | 1,941 |
Levered Free Cash Flow | -5,683 | 2,847 | -3,412 | -1,581 | 463.38 |
Unlevered Free Cash Flow | -4,359 | 4,227 | -1,810 | -527.02 | 1,327 |
Change in Working Capital | 1,394 | 1,118 | 2,531 | 543 | -1,783 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.